Kvarnhammar, Anne Månsson <br/><br/>
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation.  [electronic resource] 

 -  Journal for immunotherapy of cancer  04 2019 
 - 103 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-019-0570-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Bispecific--pharmacology<br/>CHO Cells<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Cell Line, Tumor--transplantation<br/>Cricetulus<br/>Disease Models, Animal<br/>Drug Screening Assays, Antitumor<br/>Female<br/>HEK293 Cells<br/>Humans<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Primary Cell Culture<br/>Proof of Concept Study<br/>Receptors, OX40--agonists<br/>T-Lymphocytes, Regulatory--drug effects<br/>Urinary Bladder Neoplasms--drug therapy